JPS6125711B2 - - Google Patents

Info

Publication number
JPS6125711B2
JPS6125711B2 JP54130530A JP13053079A JPS6125711B2 JP S6125711 B2 JPS6125711 B2 JP S6125711B2 JP 54130530 A JP54130530 A JP 54130530A JP 13053079 A JP13053079 A JP 13053079A JP S6125711 B2 JPS6125711 B2 JP S6125711B2
Authority
JP
Japan
Prior art keywords
methyl
isopropyl
dihydropyridine
nitrophenyl
trifluoromethylphenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP54130530A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5562065A (en
Inventor
Yoshinari Sato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of JPS5562065A publication Critical patent/JPS5562065A/ja
Publication of JPS6125711B2 publication Critical patent/JPS6125711B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/56—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups bound to carbon atoms of six-membered aromatic rings and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
JP13053079A 1978-10-10 1979-10-09 2-methyldihydropyridine derivative Granted JPS5562065A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7839978 1978-10-10

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP60214152A Division JPS61118366A (ja) 1978-10-10 1985-09-26 ２−メチルジヒドロピリジン誘導体の中間体

Publications (2)

Publication Number Publication Date
JPS5562065A JPS5562065A (en) 1980-05-10
JPS6125711B2 true JPS6125711B2 (fr) 1986-06-17

Family

ID=10500226

Family Applications (2)

Application Number Title Priority Date Filing Date
JP13053079A Granted JPS5562065A (en) 1978-10-10 1979-10-09 2-methyldihydropyridine derivative
JP60214152A Granted JPS61118366A (ja) 1978-10-10 1985-09-26 ２−メチルジヒドロピリジン誘導体の中間体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP60214152A Granted JPS61118366A (ja) 1978-10-10 1985-09-26 ２−メチルジヒドロピリジン誘導体の中間体

Country Status (10)

Country Link
JP (2) JPS5562065A (fr)
BE (1) BE879263A (fr)
CA (1) CA1117117A (fr)
CH (1) CH642353A5 (fr)
DE (1) DE2940833A1 (fr)
FR (1) FR2438654A1 (fr)
GB (1) GB2036722B (fr)
IT (1) IT1125469B (fr)
NL (1) NL7907482A (fr)
SE (2) SE446265B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7910521L (sv) * 1979-12-20 1981-06-21 Haessle Ab Nya 2-metyl-6-substituerade-4-(2,3-disubstituerad fenyl)-1,4-dihydropyridin-3,5-diestrar med hypotesiva egenskaper, samt forfarande for deras framstellning, och farmaceutiska beredningar innehallande desamma
JPS57175164A (en) * 1981-04-18 1982-10-28 Banyu Pharmaceut Co Ltd 1,4-dihydropyridine derivative and its preparation
EP0080220B1 (fr) * 1981-11-17 1986-02-19 FISONS plc Dihydropyridines, leur procédé de préparation, leurs compositions et leur application comme médicaments
ZA83959B (en) * 1982-03-10 1984-09-26 Sandoz Ltd 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them
CH655110A5 (de) * 1982-09-03 1986-03-27 Otsuka Pharma Co Ltd Carbostyrilderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten.
DE3312216A1 (de) * 1983-04-05 1984-10-11 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von symmetrischen 1,4-dihydropyridincarbonsaeureestern
JPS6038322A (ja) * 1983-08-11 1985-02-27 Fujisawa Pharmaceut Co Ltd ジヒドロピリジンａ物質含有易溶性固形製剤
GB8412208D0 (en) * 1984-05-12 1984-06-20 Pfizer Ltd Quinolone inotropic agents
GB8431119D0 (en) * 1984-12-10 1985-01-16 Fujisawa Pharmaceutical Co Anti-arteriosclerotic composition
GB8602518D0 (en) * 1986-02-01 1986-03-05 Wyeth John & Brother Ltd 1 4-dihydropyridines
JPS63115890A (ja) * 1986-10-31 1988-05-20 Nippon Shinyaku Co Ltd ２位置換１，４−ジヒドロピリジン誘導体
US5114946A (en) * 1987-06-12 1992-05-19 American Cyanamid Company Transdermal delivery of pharmaceuticals
ES2043719T3 (es) * 1987-06-12 1994-01-01 American Cyanamid Co Administracion de farmacos por via percutanea.
US5045553A (en) * 1987-06-24 1991-09-03 Fujisawa Pharmaceutical Company, Ltd. Pharmaceutical composition for percutaneous drug absorption and percutaneous drug absorption promoter
EP0323604B1 (fr) * 1987-12-29 1994-05-11 Fujisawa Pharmaceutical Co., Ltd. Agent modifiant l'extensibilité veineuse et supprimant l'hypertrophie cardiaque renfermant un composé de la dihydropyridine
EP0322747B1 (fr) * 1987-12-29 1994-03-02 Fujisawa Pharmaceutical Co., Ltd. Agent protégeant les neurones cérébraux contenant un dérivé de la dihydropyridine
JP2007230869A (ja) * 2004-04-05 2007-09-13 Takeda Chem Ind Ltd アルドステロン受容体拮抗剤
CN103951608B (zh) * 2009-08-04 2016-04-27 喜德生（苏州）医药科技有限公司 尼伐地平晶型及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1552911A (en) * 1975-07-02 1979-09-19 Fujisawa Pharmaceutical Co 1,4 dihydropyridine derivatives and the preparation thereof
GB1591089A (en) * 1976-12-17 1981-06-10 Fujisawa Pharmaceutical Co 1,4-dihydropyridine derivatives and process for preparation thereof
DE2658183A1 (de) * 1976-12-22 1978-07-06 Bayer Ag In 2-position substituierte 1,4- dihydropyridin-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
GB2036722B (en) 1982-12-01
SE8400689L (sv) 1984-02-09
GB2036722A (en) 1980-07-02
NL7907482A (nl) 1980-04-14
CA1117117A (fr) 1982-01-26
DE2940833C2 (fr) 1989-01-26
SE446265B (sv) 1986-08-25
JPS61118366A (ja) 1986-06-05
SE8400689D0 (sv) 1984-02-09
DE2940833A1 (de) 1980-04-30
SE7908367L (sv) 1980-04-11
BE879263A (fr) 1980-04-08
JPS6143343B2 (fr) 1986-09-26
IT1125469B (it) 1986-05-14
FR2438654A1 (fr) 1980-05-09
FR2438654B1 (fr) 1983-01-14
CH642353A5 (de) 1984-04-13
SE446096B (sv) 1986-08-11
IT7926362A0 (it) 1979-10-09
JPS5562065A (en) 1980-05-10

Similar Documents

Publication Publication Date Title
JPS6125711B2 (fr)
US4248873A (en) Nitro-substituted 1,4-dihydropyridines, processes for _their production and their medicinal use
CA1205480A (fr) Dihydropyridine anti-ischemique antihypertenseur, procede de production et composes pharmaceutiques les contenant
US4988717A (en) Optically active 1,4-dihydropyridine esters useful for treating circulatory illnesses
JP2001519415A (ja) ピリジル化合物およびこれを含有した薬剤組成物
WO1989007594A1 (fr) Derives de pyridazinone
JPS6339588B2 (fr)
JPH04234873A (ja) 新規な４−キノリル−ジヒドロピリジン類、その製造方法及び薬剤におけるその使用
JPH04234878A (ja) ヘテロサイクルにより置換されたジヒドロピリジン類
JPS58167570A (ja) 中枢神経系損傷を制御するためのピリジン誘導体
JPS6330911B2 (fr)
US4021434A (en) Sodium β-[2,6-dimethyl-3,5-bis(ethoxycarbonyl)-4-(3-nitrophenyl)-1,4-dihydropyridine-1-yl]ethyl sulfate
JPS59110671A (ja) １，４−ジヒドロピリジン誘導体
JPH06329667A (ja) ３−キノリル−置換ジヒドロピリジン、その製造法及び薬剤におけるその利用
JPH05186459A (ja) ２−アミノ−５−シアノ−４−キノリン−１，４−ジヒドロピリジン類
JP2007084567A (ja) フエニル−置換１，４−ジヒドロピリジン類
JPS6317068B2 (fr)
NL8004002A (nl) Chinolinederivaten en farmaceutische preparaten die een dergelijke verbinding bevatten, alsmede werkwijze voor het bereiden van deze verbindingen.
HU197304B (en) Process for producing fluor-containing 1,4-dihydro-pyridines and pharmaceutical compositions containing them
GB2050375A (en) 4-Cyanophenyl-1,4- dihydropyridine compound, processes for preparation thereof and pharmaceutical composition comprising the same
JPH0641063A (ja) ピロリジン誘導体
JPH0155268B2 (fr)
HUT70483A (en) Quinolyl-dihydropyridin-esters, process for producing them and their use for preparing pharmaceutical compositions
JPS632431B2 (fr)
KR820001835B1 (ko) 4-아미노-2-피페리디노퀴나졸린 유도체의 제조방법

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees